Larimar Therapeutics Inc (LRMR)
2.35 -0.19 (-7.48%) 14:56 ET [NASDAQ]
2.34 x 671 2.35 x 257
Realtime by (Cboe BZX)
2.34 x 671 2.35 x 257
Realtime 2.60 +0.06 (+2.36%) 09:29 ET
for Mon, Mar 24th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 26,749 | 26,825 | 70,097 | 68,148 | 1,009 |
| Marketable Securities | 60,041 | 91,603 | 0 | 24,490 | N/A |
| TOTAL | $90,175 | $120,739 | $72,204 | $97,952 | $4,750 |
| Non-Current Assets | |||||
| PPE Net | 684 | 831 | 1,049 | 1,040 | 274 |
| Other Non-Current Assets | 5,076 | 4,835 | 5,414 | 5,694 | 177 |
| TOTAL | $5,760 | $5,666 | $6,463 | $6,734 | $451 |
| Total Assets | $95,935 | $126,405 | $78,667 | $104,686 | $5,201 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,283 | 1,686 | 1,660 | 2,634 | 3,539 |
| Accrued Expenses | 7,386 | 8,408 | 6,592 | 5,843 | 2,259 |
| TOTAL | $9,506 | $10,705 | $8,846 | $8,992 | $5,895 |
| Non-Current Liabilities | |||||
| aiOther Non-Current Liabilities | 4,709 | 4,797 | 5,408 | 6,002 | 0 |
| TOTAL | $4,709 | $4,797 | $5,408 | $6,002 | $N/A |
| Total Liabilities | $14,215 | $15,502 | $14,254 | $14,994 | $5,895 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 63,800 | 43,269 | 17,710 | 15,368 | 3,121 |
| Common Shares | 43 | 43 | 18 | 15 | 6 |
| Retained earnings | -188,554 | -151,605 | -116,250 | -65,614 | -23,132 |
| Other shareholders' equity | 81 | -31 | 0 | 1 | 0 |
| TOTAL | $81,720 | $110,903 | $64,413 | $89,692 | $-694 |
| Total Liabilities And Equity | $95,935 | $126,405 | $78,667 | $104,686 | $5,201 |